Novo Nordisk has awarded a $150,000 grant to the American Diabetes Association (ADA) in support of ADA's efforts to fight discrimination against people with diabetes through the establishment of the ADA - Novo Nordisk Legal Advocacy Fellowship.

The said fellowship will provide assistance to people facing discrimination in the workplace, at school and child care centers, at correctional institutions, and in places of public accommodation, and will also work on ongoing major projects including ADA's Safe at School Campaign, which is sponsored in part by Novo Nordisk.

According to Jim Shehan, Vice President of Legal, Government & Quality Affairs, Novo Nordisk:

"Novo Nordisk is pleased and proud to support ADA's efforts to secure fair treatment for people living with diabetes. Changing diabetes is Novo Nordisk's vision and passion. So it is not enough for us to just provide innovative insulin analogs and insulin delivery systems.

We also work in various ways to be a catalyst for the changes necessary to successfully defeat the diabetes epidemic, and one important change is to end unnecessary discrimination against people with diabetes in schools, workplaces, and government institutions."

Diabetic patients interested in applying for the fellowship should contact Shereen Arent, ADA's Managing Director of Legal Advocacy at sarent@diabetes.org or visit ADA's website on diabetes discrimination.

Find more details from the full report.